Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997 Apr 15;323 ( Pt 2)(Pt 2):477-81.
doi: 10.1042/bj3230477.

S-Nitrosoglutathione as a substrate for gamma-glutamyl transpeptidase

Affiliations

S-Nitrosoglutathione as a substrate for gamma-glutamyl transpeptidase

N Hogg et al. Biochem J. .

Abstract

S-Nitrosoglutathione (GSNO) has been used as a nitric oxide (.NO) donor compound and has also been postulated to be involved in the transport of .NO in vivo. In this study we have examined the possibility that GSNO is a substrate for gamma-glutamyl transpeptidase (gamma-GT), an enzyme that hydrolyses the gamma-glutamyl moiety of glutathione to give glutamate and cysteinylglycine. gamma-GT accelerated the decomposition of GSNO, forming S-nitrosocysteinylglycine (CG-SNO) by a mechanism inhibitable by the gamma-GT inhibitors acivicin and S-methylglutathione. The Km of gamma-GT for GSNO was found to be 28 microM. In the presence of contaminating transition metal ions, gamma-GT accelerated the release of ;NO from GSNO, as CG-SNO is more susceptible to transition metal ion-dependent decomposition than GSNO. However, in the presence of the transition metal ion chelator diethylenetriaminepentaacetic acid, neither GSNO nor CG-SNO decomposed to generate .NO. Neither S-methylglutathione nor acivicin affected the vasodilatory response to GSNO in an isolated perfused rat heart. However, rat kidney homogenate stimulated the decomposition of GSNO by an acivicin-inhibitable mechanism. It is likely therefore that gamma-GT is involved in the decomposition of GSNO in the kidney but not in the heart.

PubMed Disclaimer

References

    1. Cardiovasc Res. 1994 May;28(5):691-4 - PubMed
    1. Br J Pharmacol. 1996 Oct;119(3):533-8 - PubMed
    1. Trends Pharmacol Sci. 1995 Jan;16(1):18-22 - PubMed
    1. Photochem Photobiol. 1995 Apr;61(4):325-30 - PubMed
    1. Br J Pharmacol. 1995 Mar;114(5):1083-9 - PubMed

Publication types